Ediang Duo Tablet 5/850 mg

Adult dose

The recommended dosage of this medication is 1 tablet, 2 times a day. Dosage should be determined based on each patient's current treatment regimen, efficacy and tolerance without exceeding the maximum recommended daily doses of 25 mg of empagliflozin and 2000 mg of metformin. For patients who cannot achieve adequate blood glucose control with metformin alone or in combination with other medications, the recommended dosage is 5 mg of empagliflozin twice daily.

This medication is used for the treatment of diabetes and helps in blood sugar control. Care is needed when taking this medication as a rare side effect of severe lactic acidosis may occur. Lactic acidosis can be a dangerous condition caused by the excessive accumulation of lactic acid in the body. When used in combination with other diabetic medications, hypoglycemia may occur, so it is important to be aware of symptoms of low blood sugar. Patients with moderate to severe renal impairment or specific health conditions such as acute renal problems, severe infections, or heart failure should not take this medication. Furthermore, if undergoing tests or surgeries involving iodinated contrast agents, this medication should be discontinued for a certain period, and it should only be resumed after confirming normal kidney function. Women who are pregnant or breastfeeding should not take this medication, and it is not recommended for children or adolescents under 18 years of age. This medication can lead to fluid loss, so patients with dehydration or cardiovascular disease should be cautious when taking it. During treatment, side effects such as symptoms of hypoglycemia, urinary infections, genital infections, and increased urination may occur, so immediate consultation with medical personnel is advised if symptoms arise. Vitamin B12 deficiency may occur, so for long-term use, regular blood tests to check vitamin B12 levels are advisable. Alcohol consumption may increase the risk of lactic acidosis, so it is recommended to avoid drinking while taking this medication. If sudden severe dehydration, infections, surgeries, or heart problems occur during the use of this medication, it should be immediately discontinued, and medical personnel should be notified. Moreover, when taking this medication in conjunction with insulin or sulfonylureas, the risk of hypoglycemia may necessitate dosage adjustments of the medications. Elderly patients may face increased risks of renal function decline, thus regular kidney function tests are necessary and it is advisable not to use the maximum dosage. In the case of overdose, serious side effects such as lactic acidosis may occur, so it should be taken precisely according to medical advice. Lastly, this medication should be kept out of reach of children and stored in its original packaging to maintain quality.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• severe rash with fever
• blisters
• peeling skin
• oral/eye mucosal pain

Mild side effects

• Hypoglycemia
• urinary tract infection
• genital infection
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius (room temperature) to preserve the medication's effectiveness and prevent deterioration.

Appearance

Biconvex oval film-coated tablet with a white color and a yellowish tint

Package unit

10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6), 60 tablets/bottle